Welcome to our dedicated page for Microchip Technology SEC filings (Ticker: MCHP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Microchip Technology Inc. (NASDAQ: MCHP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed information about its semiconductor business, governance and financial condition. As a Delaware corporation headquartered in Chandler, Arizona, Microchip reports as a public company on the Nasdaq Global Select Market, and its regulatory filings are a primary source for understanding MCHP stock.
On this page, investors can review Microchip’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its role as a broadline supplier of semiconductors serving industrial, automotive, consumer, aerospace and defense, communications and computing markets. These reports typically include discussions of segment performance, risk factors, research and development, and other disclosures relevant to the company’s embedded control and semiconductor portfolio.
Microchip also submits current reports on Form 8-K to announce material events. For example, an 8-K dated November 6, 2025 reports the announcement of results for the second quarter of fiscal year 2026, while an 8-K dated August 20, 2025 details the outcomes of the company’s annual meeting of stockholders, including director elections, auditor ratification and an advisory vote on executive compensation.
Definitive proxy statements on Form DEF 14A provide insight into Microchip’s governance, board composition, executive compensation and stockholder voting procedures. The July 7, 2025 proxy statement outlines the agenda for the 2025 annual meeting, the proposals presented to stockholders and information about how to vote.
Stock Titan’s SEC filings page surfaces these documents as they are made available on EDGAR and can pair them with AI-powered summaries that explain key points, such as changes in guidance, voting results or governance matters. Users can quickly locate Forms 10-K, 10-Q, 8-K and DEF 14A related to Microchip Technology, helping them analyze MCHP’s regulatory history, monitor material events and understand the disclosures that shape the company’s profile in the semiconductor industry.
Microchip Technology Inc (MCHP) Form 144/A notifies the SEC of a proposed sale of 7,356 shares of common stock by an individual account, to be brokered through Merrill in San Francisco on or about 08/25/2025 on NASDAQ. The filing shows the shares were acquired as RSUs on 08/15/2025 from Microchip Technology Inc and paid in cash on the same date. The aggregate market value of the proposed sale is listed as $508,593.84 and Microchip reports 539,679,667 shares outstanding. The filer also reported a prior sale on 05/23/2025 of 2,015 shares for gross proceeds of $112,275.80. The notice includes the standard Rule 144 representation regarding nonpublic material information.
Matthew W. Chapman, a director of Microchip Technology Inc. (MCHP), reported a sale of 10,000 shares of the issuer's common stock on 08/25/2025 at a reported price of $68.255 per share. After the sale, Mr. Chapman beneficially owned 30,665 shares, held directly. The Form 4 indicates no derivative transactions and was signed on behalf of the reporting person by an attorney-in-fact on 08/27/2025.
Microchip Technology Inc. insider James Eric Bjornholt, Senior VP and CFO, reported sales of common stock on 08/25/2025 executed under a Rule 10b5-1 trading plan. The filings show two dispositions: 3,053 shares sold at $69.14 and 4,303 shares sold at $68.42.
After these transactions the reporting person beneficially owns 34,313 and 30,010 shares in the two reported lines, held indirectly through a trust. The Form 4 notes the trading plan was adopted on May 23, 2025.
Microchip Technology, Inc. (MCHP) filed a Form 144 notifying a proposed sale of 10,000 shares of common stock through Merrill Lynch at 2049 Century Park East, Los Angeles, to be sold on 08/25/2025 on NASDAQ. The filing shows an aggregate market value of $682,551.28 for the shares and reports 539,679,667 shares outstanding for the issuer. The securities to be sold were granted as restricted stock units (RSUs) from Microchip Technology on multiple dates: 07/30/2010 (2,047 shares), 08/18/2021 (1,674 shares), 08/22/2022 (1,296 shares), 08/19/2024 (2,492 shares), and 08/18/2025 (2,491 shares). The filer reports no securities sold in the past three months and includes the standard representation that no material nonpublic information is known.
Microchip Technology, Inc. (MCHP) Form 144 notifies the SEC of a proposed sale of 7,356 shares of common stock through Merrill in San Francisco, with an aggregate market value of $508,593.84 and an approximate sale date of 08/25/2025 on NASDAQ. The filer acquired 3,053 shares as RSUs from Microchip on 08/15/2025 and indicates payment in cash on that date. The filing also discloses a prior sale on 05/23/2025 of 2,015 shares generating $112,275.80 in gross proceeds. The notice includes the standard certification that the seller is unaware of undisclosed material adverse information.
Karen Marie Rapp, a Microchip Technology Incorporated (MCHP) non-employee director, had restricted stock units vest and received shares in August 2025. On 08/18/2025, 2,491 RSUs vested at an attributable value of $65.56 per share and those vested shares were delivered, leaving the reporting person with 11,137 shares directly beneficially owned after the transaction. An additional grant of 3,090 Restricted Stock Units was reported as of 08/19/2025 that will vest in full on the earlier of one day prior to the next annual meeting or one year from grant, contingent on continued service as a non-employee director.
Victor Peng, a Microchip Technology (MCHP) director, reported transactions on Form 4 dated 08/18/2025. He acquired 2,010 shares of Microchip common stock on 08/18/2025 at a price of $65.56 per share as restricted stock units vested and were delivered. After the transaction he beneficially owned 2,326 shares indirectly, with 2,280 held by The Peng Family Revocable Trust and 46 in an IRA. Separately, a grant of 3,090 restricted stock units remains outstanding and will vest either one day before the next annual meeting or one year from grant, contingent on continued service as a non-employee director.
Matthew W. Chapman, a non-employee director of Microchip Technology Incorporated (MCHP), reported stock-based transactions dated 08/18/2025. On that date 2,491 restricted stock units vested and were delivered, recorded as an acquisition at an attributed price of $65.56 per share, increasing his direct beneficial ownership to 40,665 shares. A separate grant of 3,090 restricted stock units was reported with a transaction date of 08/19/2025; each unit represents a contingent right to one share and will vest in full on the earlier of one day prior to the next annual meeting or one year from grant, subject to continued status as a non-employee director. The form was executed by an attorney-in-fact on 08/20/2025.
Microchip Technology Inc. (MCHP) director Richard B. Cassidy II had restricted stock units (RSUs) vest and received shares on August 18, 2025. 1,258 RSUs vested and were delivered as common stock to the reporting person, recorded as an acquisition at a price field of $65.56, resulting in 1,258 shares beneficially owned following the transaction. The filing also reports an additional grant of 3,090 RSUs dated August 19, 2025, which vest in full on the earlier of one day before the next annual meeting or one year from grant, subject to continued service as a non-employee director.
Microchip Technology Inc. (MCHP) Form 4: Non‑employee director Ellen Barker received 2,491 shares upon vesting of restricted stock units on 08/18/2025, recorded as an acquisition at a reported price of $65.56 per share, bringing her beneficial ownership to 3,797 shares. The filing also shows a grant of 3,090 restricted stock units on 08/19/2025 that are recorded as derivative awards and will convert into common stock when vested. The filing states each restricted stock unit represents the right to one share and explains vesting occurs in full on the earlier of one day before the next annual meeting or one year from grant, contingent on continued service as a non‑employee director.